Revaccination with the mRNA-1345 respiratory syncytial virus (RSV) vaccine approximately 24 months after an initial dose produces immune responses
Hibah Khaja is a Principal Medical Writer at Pro-Clin Solutions. She specializes in transforming complex clinical data into clear and engaging content across various therapeutic areas, including neurology, rheumatology, psychiatry, and gastroenterology, with a strong focus on evidence-based healthcare communication. Hibah's work has been featured in prominent publications such as Renal & Urology News, Cancer Therapy Advisor, and The Clinical Advisor, among others.





